The pharmaceutical industry faces increasingly robust challenges in a scenario of high regulatory requirements, constant digital transformation, in addition to the growing demand for operational efficiency. Faced with such challenges, the search for excellence in service levels, ensuring deliveries“on time and in full”(OTIF), and the optimization of investments in technology, emerge as determining factors for the competitiveness of the sector which, in 2023, had a turnover of R$ 142 billion in Brazil.
The pursuit of on-time delivery is not just a matter of customer satisfaction, but a competitive advantage. Alignment between demand planning, inventory management and logistics processes becomes essential to achieve high levels of OTIF.
Although there is no specific data on the OTIF deficit in the sector, companies that implement lean manufacturing practices and global production strategies have demonstrated improvements in indicators such as inventory levels, OTIF deliveries and reduction of lead times. To achieve this, some practices can be adopted:
- More accurate demand forecasting: The use of Artificial Intelligence and predictive analysis makes it possible to anticipate consumption patterns, avoiding unnecessary stocks and supply disruptions.
- Supply chain improvement: Investing in strategic partnerships and digital integration between suppliers, distributors and logistics operators reduces bottlenecks and improves the traceability of medicines.
- Automation and digitalization of processes: Tools such as logistics control towers, IoT (Internet of Things) and blockchain enable greater visibility and control over the flow of products, minimizing failures and guaranteeing deliveries.
Technology as a vector of transformation
Optimizing technology investments must be guided by a strategic vision, encompassing everything from organizational structure to data security and process automation. Some key areas are worth highlighting:
- Organizational structure and agile squads: The adoption of agile methodologies and the creation of multidisciplinary squads increase the capacity for innovation and rapid response to market changes, allowing greater efficiency in the execution of technology projects.
- Data platform and cloud computing: The unification of data on robust and secure platforms, combined with migration to the cloud, allows for greater scalability, accessibility and strategic insights based on data analysis.
- Cybersecurity as a priority: The pharmaceutical industry handles sensitive and high-value information. Implementing rigorous security policies, including advanced encryption, continuous monitoring and employee training, is essential to mitigate cyber risks.
- Process automation and artificial intelligence: From chatbots for customer service to process automation (RPA) robots for administrative tasks, AI has the potential to reduce operational costs and increase productivity.
The future of the pharmaceutical sector will be defined by companies’ ability to balance technological innovation with operational efficiency. Those that can align technology investments with the pursuit of logistical excellence will be better positioned to face challenges and offer superior service. Commitment to innovation and digital transformation is not only a competitive advantage, but an imperative for the survival and sustainability of the business.
